Implication of maternal-cell contamination in the clinical banking of umbilical cord blood

References

• Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl 7 Med 1989;321:1174–8.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic siblingumbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346:214–19.
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Laughlin M, Graham ML et al. Placental bloodas a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl 7 Med 1996;335:157–66.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Rosenthal J, Sweetman R et al. Successful trans-plantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88:795–802.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl y Med 1997;337:373–81.
   Google Scholar
• Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl y Med 1998;339:1565–77.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplanta-tion. Rev Clin Exp Hematol 2001;5:87–99.
   Google Scholar
• Harris DT, Schumacher MJ, Locascio J et al. Phenotypic andfunctional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992;89:10006–10.
   PubMed Web of Science ®Google Scholar
• Rocha V, Wagner JE, Sobocinski KA et al. Graft-versus-hostdisease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl y Med 2000;342:1846–54.
   Google Scholar
• Schroder J. Transplacental passage of blood cells. 7 Med Genet 1975;12:230–42.
   PubMed Web of Science ®Google Scholar
• Linch DC, Brent L. Marrow transplantation. Can cord blood be used? Nature 1989;340:676.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Dobrila L, Rosenfield RE et al. Processing andcryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119–22.
   PubMed Web of Science ®Google Scholar
• Tsang KS, Li K, Huang DP et al. Dextran sedimentation in a semi-closed system for the clinical banking of umbilical cord blood. Transfusion 2001;41:344–52.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Anderson L, Keeney M et all The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. 7 Hematother 1996;5:213–26.
   PubMedGoogle Scholar
• Kam KM, Leung WL, Kwok MY et al. Lymphocyte subpop-ulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin Diagn Lab Immunol 1996;3:326–30.
   PubMedGoogle Scholar
• Netcord-FAHCT. International standards for cord blood collec-tion, processing, testing, banking, selection and release. Netcord and Foundation for the Accreditation of Hematopoietic cell therapy, 2001.
   Google Scholar
• Fraser JK, Cairo MS, Wagner EL et al. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. 7 Hematother 1998;7:521–61.
   PubMedGoogle Scholar
• Jefferies LC, Albertus M, Morgan MA et al. High deferral rate for maternal—neonatal donor pairs for an allogeneic umbilical cord blood bank. Transfusion 1999;39:415–19.
   PubMed Web of Science ®Google Scholar
• Lecchi L, Ratti I, Lazzari L et al. Reasons for discard of umbilical cord blood units before cryopreservation. Transfusion 2000;40:122–4.
   PubMed Web of Science ®Google Scholar
• McCullough J, Herr G, Lennon S et al. Factors influencing the availability of umbilical cord blood for banking and transplantation. Transfusion 1998;38:508–10.
   PubMed Web of Science ®Google Scholar
• Hunziker RD, Gambel P, Wegmann TG. Placenta as a selective barrier to cellular traffic. 7 Immunol 1984; 133:667–71.
   Google Scholar
• Hunziker RD, Wegmann TG. Placental immunoregulation. C Mt Rev Immunol 1986;6:245–85.
   PubMed Web of Science ®Google Scholar
• Kernan NA, Collins NH, Juliano L et al. Clonable T lym-phocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986;68:770–3.
   PubMed Web of Science ®Google Scholar
• Abecasis MM, Machado AM, Boavida G et al. Haploidentical cord blood transplant contaminated with maternal T cells in a patient with advanced leukaemia. Bone Marrow Transplant 1996;17:891–5.
   PubMed Web of Science ®Google Scholar
• Ilhan 0, Akan H, Koc H et al. Incidence of graft vs host dis-ease in allogeneic bone marrow transplantation in a single center study from Turkey. Hematol Cell Ther 1997;39:133–6.
   Google Scholar
• Harada M, Takenaka K, Nakao S et al. [Nationwide survey of allogeneic peripheral blood stem cell transplantation from related donors in Japan: current trends and issues.] Rinsho Ketsueki 1999;40:1160–7.
   PubMedGoogle Scholar
• Harris DT, Schumacher MJ, Locascio J et al. Immuno-reactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical trans-plantation. Bone Marrow Transplant 1994;14:63–8.
   PubMedGoogle Scholar
• Tamaki S, Ichinohe T, Matsuo K et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant 2001;28:375–80.
   PubMed Web of Science ®Google Scholar
• Varadi G, Elchalal U, Brautbar C et al. Human umbilical cord blood for hematopoietic progenitor cells transplanta-tion. Leuk Lymph 1995;20:51-8.1 Gluckman E.
   Google Scholar
• Olding LB, Oldstone BA. Thymus-derived peripheral lym-phocytes from human newborns inhibit division of their mothers' lymphocytes. 7 Immunol 1976;116: 682–6.
   Google Scholar
• Oldstone MB, Tishon A, Moretta L. Active thymus derived suppressor lymphocytes in human cord blood. Nature 1977;269:333–5.
   Google Scholar
• Jacoby DR, Olding LB, Oldstone MB. Immunologic regu-lation of fetal—maternal balance. Adv Immunol 1984;35: 157–208.
   PubMedGoogle Scholar
• Fietz T, Hilgenfeld E, Berdel WE et al. Ex vivo expansion of human umbilical cord blood does not lead to co-expansion of contaminating maternal mononuclear cells. Bone Marrow Transplant 1997;20:1019–26.
   PubMed Web of Science ®Google Scholar
• Hall JM, Lingenfelter P, Adams SL etal. Detection of mater-nal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 1995;86:2829–32.
   Google Scholar
• Petit T, Gluckman E, Carosella E et al. A highly sensitive polymerase chain reaction method reveals the ubiquitouspresence of maternal cells in human umbilical cord blood. Exp Hematol 1995;23:1601–5.
   PubMed Web of Science ®Google Scholar
• Scaradavou A, Carrier C, Mollen N et al. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 1996;88:1499–500.
   Web of Science ®Google Scholar
• Almici C, Carlo-Stella C, Rizzoli V et al. Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping. Blood 1996;88:1520–1.
   PubMedGoogle Scholar
• Poli F, Sirchia SM, Scalamogna M et al. Detection of maternal DNA in human cord blood stored for allotrans-plantation by a highly sensitive chemiluminescent method. Hematother 1997;6:581–5.
   PubMedGoogle Scholar
• Engel H, Kaya E, Bald R et al. Fetal cord blood as an alter-native source of hematopoietic progenitor cells: immunophenotype, maternal cell contamination, and ex vivo expansion. 7 Hematother 1999;8:141–55.
   PubMedGoogle Scholar